Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
The most commonly associated medications shared across diseases were osmotic laxatives (n = 231 diseases), vitamin D (n = 211 diseases), stimulant laxatives (n = 202 diseases), control of epilepsy medication (n = 201) and drugs used in megaloblastic anemias (eg, folic acid) (n = 199 diseases).
Source: Validity assessment through disease-medication profiling. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Volunteers aged 40-69 attended assessment centers in England, Scotland, and Wales between 2006 and 2010 to complete self-reported questionnaire data, undergo baseline assessment of physiological measurements, and consent to sharing of EHR for study follow-up.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Harmonizing UK primary care prescription records for research: a case study in the UK biobank
Study design awaiting verification · JAMIA Open · 2026
Original publication title
Harmonizing UK primary care prescription records for research: a case study in the UK biobank
© The Author(s) 2026. Published by Oxford University Press on behalf of the American Medical Informatics Association.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
We aimed to develop and validate an automated, scalable framework to harmonize fragmented UK primary care prescription records into a research-ready dataset by mapping diverse medical ontologies to a unified reference standard from the UK Biobank.
Source: ObjectiveAbstract: What methods does the paper describe?
Preprocessing involved selecting a single drug code where multiple were recorded, cleaning codes to match reference presentations, expanding code granularity via drug descriptions, and updating outdated codes. Harmonization mapped British National Formulary (BNF) and Read2 codes to dm+d, the National Health Service standard vocabulary, with records then homogenized to the Virtual Medicinal Product (VMP) granularity. We validated our approach by profiling prescribing patterns across 312 diseases.
Source: Materials and methodsAbstract: Discussion
Our framework addresses a longstanding barrier to large-scale pharmacoepidemiological research by reconciling heterogeneous coding systems into a single, consistent standard. The high conversion rate to VMP demonstrates near-complete coverage, while the recovery of plausible drug-indication associations supports validity. Limitations include residual uncodable records and dependence on dm+d completeness.
Source: DiscussionAbstract: Results
We preprocessed 57 659 844 records from 221 868 participants; we dropped 48 950 records for missing drug codes and 13% used multiple ontologies. Most records were BNF-encoded (76%), and 49% required granularity expansion via drug description. In total, 72% of records were harmonized to dm+d, of which 99.98% were converted to VMP. Across 312 diseases, we identified 23 352 disease-drug associations involving 237 medications (BNF subparagraphs) that survived statistical correction, most resembling drug-indication pairs.
Source: ResultsAbstract: Conclusion
Our approach transforms fragmented prescription records into a streamlined, enriched dataset suitable for large-scale discovery research.
Source: ConclusionAuthors’ abstract
Abstract
Objective
We aimed to develop and validate an automated, scalable framework to harmonize fragmented UK primary care prescription records into a research-ready dataset by mapping diverse medical ontologies to a unified reference standard from the UK Biobank.
Materials and methods
Preprocessing involved selecting a single drug code where multiple were recorded, cleaning codes to match reference presentations, expanding code granularity via drug descriptions, and updating outdated codes. Harmonization mapped British National Formulary (BNF) and Read2 codes to dm+d, the National Health Service standard vocabulary, with records then homogenized to the Virtual Medicinal Product (VMP) granularity. We validated our approach by profiling prescribing patterns across 312 diseases.
Results
We preprocessed 57 659 844 records from 221 868 participants; we dropped 48 950 records for missing drug codes and 13% used multiple ontologies. Most records were BNF-encoded (76%), and 49% required granularity expansion via drug description. In total, 72% of records were harmonized to dm+d, of which 99.98% were converted to VMP. Across 312 diseases, we identified 23 352 disease-drug associations involving 237 medications (BNF subparagraphs) that survived statistical correction, most resembling drug-indication pairs.
Discussion
Our framework addresses a longstanding barrier to large-scale pharmacoepidemiological research by reconciling heterogeneous coding systems into a single, consistent standard. The high conversion rate to VMP demonstrates near-complete coverage, while the recovery of plausible drug-indication associations supports validity. Limitations include residual uncodable records and dependence on dm+d completeness.
Conclusion
Our approach transforms fragmented prescription records into a streamlined, enriched dataset suitable for large-scale discovery research.
Publication and source details
Original title: Harmonizing UK primary care prescription records for research: a case study in the UK biobank
Cai R Ytsma; Ana Torralbo; Natalie K Fitzpatrick; Maik Pietzner; Daniela Nguyen; Ioannis Louloudis; Sabrina Ansarey; Spiros Denaxas
JAMIA Open · 2026
Corresponding authors: Ana Torralbo, PhD, Institute of Health Informatics, University College London, London, NW1 2DA, United Kingdom (rmhicyt@ucl.ac.uk) and Cai R. Ytsma, MSc, Institute of Health Informatics, University College London, London, NW1 2DA, United Kingdom (a.torralbo@ucl.ac.uk)© The Author(s) 2026. Published by Oxford University Press on behalf of the American Medical Informatics Association.2026https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. GSK10.13039/100004330Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:36:41.488458+00:00
DOI: 10.1093/jamiaopen/ooag190 · PMC13630483